Who VivioMD May Be Right For This section is designed to help you figure out whether VivioMD aligns with your specific situation
It may be used as a diagnostic measure to identify the cause of the fluid accumulation, for example, infection, gout, or rheumatoid arthritis, or as a therapeutic intervention to relieve pressure and discomfort
If your protocol requires frequent high-volume injections, a lower concentration of 400mcg/mL (2.5mL bacteriostatic water) may be more practical
Clinical trials show semaglutide (Wegovy) produces average weight loss of approximately 15% over 68 weeks, liraglutide (Saxenda) around 810% over one year, and tirzepatide over 20% in some participants, all combined with lifestyle interventions
Volkov I, Rudoy I, Freud T, et al